Version 1.1 · published August 2026

The Standard

Eight criteria for screening a United States peptide seller. Each criterion states a requirement, a check method, and what fails. The ledger records every seller against every criterion, with dates.

The Standard screens the seller, not the peptide. A criterion is checkable against the seller's own published material or a public register. Revisions are versioned; the changelog records every change.

The Standard applied to the field

What the eight criteria produced when checked against every seller in the ledger, on the date stated above.

S1 Prescriber requirement535 pass · 44 fail · 7 not verified
S2 Prescription gating436 pass · 91 fail · 59 not verified
S3 Pharmacy identification244 pass · 331 fail · 11 not verified
S4 Compounding disclosure409 pass · 158 fail · 19 not verified
S5 Analytical documentation38 pass · 539 fail · 9 not verified
S6 Business address418 pass · 160 fail · 8 not verified
S7 Price disclosure525 pass · 48 fail · 13 not verified
S8 Enforcement status584 pass · 0 fail · 2 not verified
  • Pass
  • Fail
  • Not verified

The eight criteria, compared

Eight criteria read faster side by side than as eight separate sections. This is a short form of each; the full requirement, method and failure condition are printed once, in full, below.

CodeRequirementWhat fails
S1A licensed United States clinician evaluates each order before any drug ships.A checkout that never mentions a clinician fails S1.
S2The product cannot be bought without a medical evaluation.An add-to-cart button on a semaglutide vial fails S2.
S3The seller names the pharmacy that fills its orders.The phrase 'a licensed US partner pharmacy' names nothing and fails S3.
S4A seller of compounded drugs says so plainly.Marketing a compounded product under a brand drug's name with no compounding language fails S4.
S5The seller publishes analytical evidence for what it ships.The word 'lab-tested' with no reachable document fails S5.
S6A physical United States address for the operating business is disclosed on the site.A contact form with no address fails S6.
S7The price is published before intake or checkout begins.The phrase 'see pricing after your consultation' fails S7.
S8No FDA enforcement action has stopped the seller from operating.An injunction, consent decree, seizure, or closure that halts the business fails S8.

Every criterion, in full

S1.Prescriber requirement

A licensed United States clinician evaluates each order before any drug ships. The seller states this on its own pages.

Check method

The seller's published pages are read for prescriber language. The claim is recorded with its URL and the date read.

What fails: A checkout that never mentions a clinician fails S1. A site selling peptides labeled for research fails S1 by design. Full criterion →

S2.Prescription gating

The product cannot be bought without a medical evaluation. Payment alone must not produce a shipment.

Check method

The public order path is read up to, never past, the intake step. Add-to-cart commerce with no eligibility step fails.

What fails: An add-to-cart button on a semaglutide vial fails S2. An intake form that is optional fails S2. Full criterion →

S3.Pharmacy identification

The seller names the pharmacy that fills its orders. The name must identify a real facility.

Check method

The terms, the frequently asked questions, the footer and the shipping or fulfillment page are read for a pharmacy presented as the filling facility. A name plus a state records as satisfied, and a failure names the surfaces that were read.

What fails: The phrase 'a licensed US partner pharmacy' names nothing and fails S3. So does silence. Full criterion →

S4.Compounding disclosure

A seller of compounded drugs says so plainly. The disclosure states that compounded products are not FDA-approved.

Check method

Product and FAQ pages are read for the words compounded and FDA-approved. Placement must be reader-visible, not buried in terms.

What fails: Marketing a compounded product under a brand drug's name with no compounding language fails S4. Full criterion →

S5.Analytical documentation

The seller publishes analytical evidence for what it ships. A certificate of analysis or equivalent lot documentation qualifies.

Check method

The seller's pages are searched for certificates, HPLC reports, or lot testing. The document must be reachable, not merely mentioned.

What fails: The word 'lab-tested' with no reachable document fails S5. Full criterion →

S6.Business address

A physical United States address for the operating business is disclosed on the site.

Check method

Footer, contact, terms, and privacy pages are read for a street address. A registered-agent address records with a note.

What fails: A contact form with no address fails S6. A PO box records as satisfied, with a note. Full criterion →

S7.Price disclosure

The price is published before intake or checkout begins. The number, not a starting-at tease behind a form.

Check method

Public pages are read for stated prices. A price shown only after sign-up records as failed.

What fails: The phrase 'see pricing after your consultation' fails S7. Full criterion →

S8.Enforcement status

No FDA enforcement action has stopped the seller from operating. Any warning letter naming the entity is disclosed on its record.

Check method

The full FDA warning-letter index is downloaded and searched locally, with a known-positive control letter proving the search works. Hits are attributed by entity and address, never by name resemblance, then read to record what the letter alleges and whether the seller still operates.

What fails: An injunction, consent decree, seizure, or closure that halts the business fails S8. A warning letter alone does not: it is recorded and dated on the seller record instead. Full criterion →

Open the ledger→